NCT07459647Phase 2Recruiting

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

Study sponsor: MapLight Therapeutics

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2030-02Estimated
Enrollment · participants500Estimated
Source updated2026-09-01Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Recruitment status changed

− Before

Not yet recruiting

+ After

Recruiting

Check registry source